Mr Luiz Penalva, OCCUPATIONAL THERAPI in Rustburg, VA - Occupational Therapist

Mr Luiz Penalva, OCCUPATIONAL THERAPI is a Occupational Therapist based in Rustburg, Virginia. Mr Luiz Penalva is licensed to practice in * (Not Available) (license number ) and his current practice location is 1051 Village Hwy, Unit J, Rustburg, Virginia. He can be reached at his office (for appointments etc.) via phone at (434) 332-4240.

NPI number for Mr Luiz Penalva is 1942400098 and his current mailing address is 1051 Village Hwy, Unit J, Rustburg, Virginia. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1942400098.

Contact Information

	Mr Luiz Penalva, OCCUPATIONAL THERAPI
	1051 Village Hwy, Unit J, Rustburg, VA 24588-3800
	(434) 332-4240
	Not Available

Healthcare Provider's Profile

Full Name	Mr Luiz Penalva
Gender	Male
Speciality	Occupational Therapist
Location	1051 Village Hwy, Rustburg, Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1942400098
Provider Enumeration Date: 07/18/2007
Last Update Date: 07/18/2007

Medical Identifiers

Medical identifiers for Mr Luiz Penalva such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942400098	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Luiz Penalva is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Luiz Penalva, OCCUPATIONAL THERAPI 1051 Village Hwy, Unit J, Rustburg, VA 24588-3800 Ph: (434) 332-4240	Mr Luiz Penalva, OCCUPATIONAL THERAPI 1051 Village Hwy, Unit J, Rustburg, VA 24588-3800 Ph: (434) 332-4240

News Archive

Kansas breast and cervical cancer screening program for low-income, uninsured women runs out of funding

The Kansas Early Detection Works program, which provides uninsured low-income women in the state with breast and cervical cancer screenings at no cost, has depleted its operating funds and will delay almost all cancer screenings until July 1, the Wichita Eagle reports.

New multicenter trial achieves 71% survival in AML children

More individualized therapy and better supportive care helped push the survival for children with acute myeloid leukemia (AML) to 71 percent three years after diagnosis, according to new research led by St. Jude Children's Research Hospital investigators and reported in the medical journal The Lancet Oncology. The survival rate of 71 percent is 20 percent better than previously reported U.S. rates and is similar to the success achieved in a 2009 Japanese study, said Jeffrey Rubnitz, M.D., Ph.D., a member of the St. Jude Oncology department.

Highlights of January 2010 'Ophthalmology'

This month's Ophthalmology, the journal of the American Academy of Ophthalmology, includes a research review of the effects of Vitamins C and E and magnesium on diabetic retinopathy and findings from the first large study of vision problems in Hispanic and African-American infants and young children.

Impact of prior SARS-CoV-2 infection and vaccine on antibody levels: Texas survey

A collaborative team, led by principal investigator Dr. Eric Boerwinkle, at The University of Texas Health Science Center at Houston, School of Public Health is conducting a survey designed to assess the frequency of antibody-positive individuals across Texas. The TEXAS Coronavirus Antibody REsponse Survey (CARES) aims to look for antibodies in the blood made in response to natural SARS-CoV-2 infection or vaccination.

EMA CHMP adopts positive opinion for ELIQUIS to prevent stroke, systemic embolism in NVAF patients

Bristol-Myers Squibb and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending that ELIQUIS (apixaban) be granted approval for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) and one or more risk factors for stroke.

Mr Luiz Penalva, OCCUPATIONAL THERAPI - Occupational Therapist in Rustburg, VA